Women's_Rogaine - Drug Details
📊 Estimates Women's_Rogaine Dialyzability By Different_Modalities

Women's_Rogaine

Complete Drug Information

Drug Name
Women's_Rogaine
Trade Names
Loniten, Rogaine
Pregnancy Category
AU: C
Bioavailability
Oral: ≥90% (absorption)Topical: ~1.2–1.4%
Routes of Administration
Oral, sublingual, topical (solution, foam, spray)
Protein Binding
Minimal or negligible%
Metabolism
Primarily liver via glucuronidation, hydroxylation, and sulfation (SULT1A1, SULT2A1)
Elimination
Oral: 3–4 hoursTopical: 22 hours
Excretion
Urine: >97% (10–15% unchanged; within 12–20 hours for oral and 4 days for topical)
Formula
C9H15N5O
Molar Mass
209.253
Onset of Action
30–60 min
Duration of Action
72 hour
Melting Point
248 °C
Drug Class
Potassium channel opener; KATP channel opener
Volume of Distribution
C9H15N5O

🤰 Pregnancy Category Information

Category: AU: C

Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible.